<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/47557C21-EC38-466F-A57D-D585FA6B783F"><gtr:id>47557C21-EC38-466F-A57D-D585FA6B783F</gtr:id><gtr:firstName>Eva-Maria</gtr:firstName><gtr:surname>Frickel</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UP_1202%2F12"><gtr:id>FA7D2D97-5AE4-42D9-A4CE-34D8149B4F6E</gtr:id><gtr:title>A new perspective on anti-Toxoplasma gondii immunity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UP_1202/12</gtr:grantReference><gtr:abstractText>Toxoplasma gondii is a pathogen related to the malaria parasite with a wide range of host specificity that includes humans. It can cause brain disease and is a serious health threat to individuals with a poorly functioning immune system, including newborns. No vaccines or drugs to fight the disease are available and once infected the parasite remains with the host its whole life. We don't exactly know how Toxoplasma maintains the intricate balance between survival inside a host and elimination. 
We study how the host cell redesigns and controls the composition of its membrane system and the sites to which the parasite has access directly following infection. These same controls enable the immune system to &amp;quot;see&amp;quot; which cells are infected. Proteins called large GTPases are upregulated in infected cells and brought to the membrane of the enclosure in which the parasites multiply. We investigate how this recruitment contributes to the parasites?s survival or elimination. 
Moreover, we have created mice that bear large numbers of immune cells, capable of specific recognition of Toxoplasma. We will ask how these specific immune cells control the infection with Toxoplasma in the chronic phase. This is especially important, as clinically the parasite lies permanently dormant due to the pressure these cells exert in normal individuals. 
Understanding these parameters of parasite control will contribute to the design of effective countermeasures against Toxoplasma.</gtr:abstractText><gtr:technicalSummary>The protozoan parasite Toxoplasma gondii infects a broad range of hosts, with a seroprevalence in man of about 30%. It is unclear how Toxoplasma maintains the intricate balance between survival and host defence. IFN?, the main cytokine responsible for its control, activates cells to restrict intracellular parasite replication or to kill intracellular Toxoplasma. Cell-mediated immunity, driven mostly by CD8 T cells, confers resistance to the chronic phase of the parasite. The outcome of an infection with Toxoplasma is determined not only by the host's immune status, but also by the genotype of the infecting strain. The major cause of Toxoplasma pathogenesis results from parasite burden, concurrent with an over-stimulation of the immune system in the form of high levels of T helper cell type 1 cytokines, increased apoptosis and organ damage.

Among the proteins highly upregulated as a consequence of interferon-stimulated transcription are the p65 GTPases (GBPs), members of the family of large GTPases that mediate resistance to intracellular pathogens. Contrary to the p47 class of GTPases, the GBPs are present in multiple copies in both the mouse and human genome. Even though the structure of human GBP1 has been solved and the ability of some family members to hydrolyze GTP to GDP and then to GMP is established, limited in vivo role for this class of enzymes have been assigned and few interaction partners are known. We will investigate the mode of action as well as the function of this class of GTPases on the vacuole of Toxoplasma in a parasite virulence-dependent fashion.

Through their production of IFN?, CD8 T cells are important in conferring resistance against Toxoplasma. After an infection with Toxoplasma, both CD4 and CD8 T cells infiltrate the brain. Thus far only transgenic parasites expressing model antigens in combination with transgenic T cells have been used as models for infection. Obvious shortcomings of this approach include difficulties in controlling expression levels and localization of the antigen. Moreover, the model transgenic T cell receptors might not recognise the model antigen with physiological affinity. 

We and others have identified 3 H-2Ld and 1 H-2Kb restricted CD8 T cell epitope derived from Toxoplasma proteins. Using flow cytometry to sort antigen-specific CD8 T cells from Toxoplasma-infected BL/6 x Balb/c F1 mice, transnuclear (TN) Toxoplasma-specific CD8 T cell receptor (TCR) mice for all four of these Toxoplasma epitope-MHC complexes (Ld-Rop7, Ld-Gra4, Ld-Gra6 and Kb-tgd057) have been generated by somatic cell nuclear transfer. We have three lines of mice with unique TCR sequences that all recognize Ld-Rop7, thus enabling further studies on how the binding affinity of the TCR to the MHC controls parasite burden and dictates memory CD8 T cell properties during the chronic phase of infection. 

Our long-term goal is to identify novel pathways and mechanisms of host resistance to Toxoplasma.</gtr:technicalSummary><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-07-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1064543</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>NIMR Open Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1F1E3499-1044-4156-A490-816844A7BE31</gtr:id><gtr:impact>This was part of the NIMR open day meant to engage the public in North London. I gave a 15 minute presentation followed by questions from the audience.

The open day including my talk was advertised and later summarised on social media.</gtr:impact><gtr:outcomeId>pjkJR6EagyD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>St Paul School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>785AA886-028A-4630-861A-84FE70B8C45D</gtr:id><gtr:impact>Talk sparked questions from the students.</gtr:impact><gtr:outcomeId>546250c4993968.31136545</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Teaching an MSc module for London School of Hygiene and Tropical Medicine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6FF0CCD1-5671-4B2E-BB70-E1771DC4B206</gtr:id><gtr:impact>1.5h lecture on Immunity to Toxoplasma gondii to MSc students at the London School of Hygiene and Tropical Medicine</gtr:impact><gtr:outcomeId>56dd6d107d2716.40661713</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIMR Centenary Day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A8FA8DD7-08AF-4C20-B2BF-7CBF08CC5893</gtr:id><gtr:impact>Talk enabled a broader recognition of our work and lead to discussions with peer scientists.

The talk lead to further discussions with scientists within the institute and from abroad.</gtr:impact><gtr:outcomeId>54625047683694.40907657</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Teaching an MSc module for London School of Hygiene and Tropical Medicine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1E979A8B-1D6E-4F0B-9422-18BC8C11003C</gtr:id><gtr:impact>I teach a 1.5h MSc level class on Immunity to Toxoplasma gondii.</gtr:impact><gtr:outcomeId>58c9a8e7601e08.54616927</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIMR School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E2F130E5-20CE-4ACA-8F38-20F1190EB93C</gtr:id><gtr:impact>Talk stimulated students to ask questions.</gtr:impact><gtr:outcomeId>546250f99502b2.11106007</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL LMCB Immunology and Infection Master's Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>67A5F012-2BA9-4721-AE30-8BC119805FA7</gtr:id><gtr:impact>I teach a 2h class based on literature reading discussing a topic within Immunity to Toxoplasma gondii.</gtr:impact><gtr:outcomeId>58c9a9309362d3.62492369</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Boehringer Ingelheim PhD Fellowship</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Boehringer Ingelheim</gtr:fundingOrg><gtr:id>5BF1968F-BFF7-4CD9-89E3-0624215DB406</gtr:id><gtr:outcomeId>hQhDZYpyHqS</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Career Development Award</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>41934DE6-55FB-4FA4-8B8B-2889E1952462</gtr:id><gtr:outcomeId>BrUwCdQHgKr</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have successfully set up the production of induced pluripotent stem cell-derived macrophages. My postdoc Rabia Khan did this work receiving help and guidance from Lyn Healy at the Crick. They used protocols sourced from Sally Cowley in Oxford in an agreement of collaboration. The iPSC line is under MTA with the Sanger.</gtr:description><gtr:id>1C7BE917-3FE3-4609-8837-AF93E1F8E59C</gtr:id><gtr:impact>We will use these cells in the future to study the impact of human immune defence mechanisms on Salmonella and Toxoplasma. Additionally, we will use these cells to study general mechanisms of action of the Guanylate Binding Proteins.</gtr:impact><gtr:outcomeId>58c9aa2909c0c2.64786463</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>iPSC-derived macrophages</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2017</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>933213C4-9D87-4ED3-B458-F0B7795CB38F</gtr:id><gtr:title>TRIM21 is critical for survival of Toxoplasma gondii infection and localises to GBP-positive parasite vacuoles.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7923a224e1a74de8e3b89aae25a496e"><gtr:id>b7923a224e1a74de8e3b89aae25a496e</gtr:id><gtr:otherNames>Foltz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa656aad71897.92473786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC71B57B-2A77-41B5-A289-99986EE39747</gtr:id><gtr:title>Human GBP1 does not localize to pathogen vacuoles but restricts Toxoplasma gondii.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f139fccb2691ae756a9518bf12b3f3fa"><gtr:id>f139fccb2691ae756a9518bf12b3f3fa</gtr:id><gtr:otherNames>Johnston AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>56dd664b9c90b0.33263887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F24203E6-C303-4B71-8A3D-35BD78F88835</gtr:id><gtr:title>The Toxoplasma Parasitophorous Vacuole: An Evolving Host-Parasite Frontier.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd444ef1fd890ab267251a70b0f22fca"><gtr:id>fd444ef1fd890ab267251a70b0f22fca</gtr:id><gtr:otherNames>Clough B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>5aa656aa733b74.69002510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BF92E21-B9F6-452A-A2CD-143A896F3511</gtr:id><gtr:title>Cell death of gamma interferon-stimulated human fibroblasts upon Toxoplasma gondii infection induces early parasite egress and limits parasite replication.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad98ff642aa10ef67e1cd99e95744806"><gtr:id>ad98ff642aa10ef67e1cd99e95744806</gtr:id><gtr:otherNames>Niedelman W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>pm_23758_28_24042117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9C7301B-C365-4289-979B-17639AC36363</gtr:id><gtr:title>Peripheral self-reactivity regulates antigen-specific CD8 T-cell responses and cell division under physiological conditions.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c9be987fd5771a904dcf627292d52ca"><gtr:id>7c9be987fd5771a904dcf627292d52ca</gtr:id><gtr:otherNames>Swee LK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>58c96b42c36401.82099333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B2FCCC0-1982-4835-A19B-D35D87673A92</gtr:id><gtr:title>Transnuclear CD8 T cells specific for the immunodominant epitope Gra6 lower acute-phase Toxoplasma gondii burden.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fceb02eb115888f6523c16fe673cbf7"><gtr:id>9fceb02eb115888f6523c16fe673cbf7</gtr:id><gtr:otherNames>Sanecka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>58c96b427457f2.14830688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53A3C411-B12E-4E16-9E10-28BDDA77EF4C</gtr:id><gtr:title>Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b16a0c0ab1676faac64274e8742c115"><gtr:id>7b16a0c0ab1676faac64274e8742c115</gtr:id><gtr:otherNames>Haldar AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56dd664c616135.28644342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D19BFAEC-D0C3-4A26-9EAE-724299D52A7E</gtr:id><gtr:title>Detection of Cytosolicvia a C-Terminal Triple-Arginine Motif of GBP1 Inhibits Actin-Based Motility.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a75f03e2707456035936c08a30d8b0"><gtr:id>26a75f03e2707456035936c08a30d8b0</gtr:id><gtr:otherNames>Piro AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa656aba2b3b7.42879700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96FEC52E-7C61-4CE9-8ACE-815F85BC7FC4</gtr:id><gtr:title>Use and abuse of dendritic cells by Toxoplasma gondii.</gtr:title><gtr:parentPublicationTitle>Virulence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fceb02eb115888f6523c16fe673cbf7"><gtr:id>9fceb02eb115888f6523c16fe673cbf7</gtr:id><gtr:otherNames>Sanecka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2150-5594</gtr:issn><gtr:outcomeId>pm_23758_28_23221473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C86BF8A5-9868-49C1-AE4A-7F9CCB822837</gtr:id><gtr:title>IRG and GBP host resistance factors target aberrant, &amp;quot;non-self&amp;quot; vacuoles characterized by the missing of &amp;quot;self&amp;quot; IRGM proteins.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b16a0c0ab1676faac64274e8742c115"><gtr:id>7b16a0c0ab1676faac64274e8742c115</gtr:id><gtr:otherNames>Haldar AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>54625160b18c68.20085979</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03D35BF0-11C2-45F8-932D-E8B3506D3E7B</gtr:id><gtr:title>RabGDIa is a negative regulator of interferon-?-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondii.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cbff7d98908e0a7d2cece1ee774a46a"><gtr:id>8cbff7d98908e0a7d2cece1ee774a46a</gtr:id><gtr:otherNames>Ohshima J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5675e9c3298f3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8DA3274-2D15-4870-A835-5EA26420EB22</gtr:id><gtr:title>Chlamydia trachomatis Is Resistant to Inclusion Ubiquitination and Associated Host Defense in Gamma Interferon-Primed Human Epithelial Cells.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b16a0c0ab1676faac64274e8742c115"><gtr:id>7b16a0c0ab1676faac64274e8742c115</gtr:id><gtr:otherNames>Haldar AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c96b430bb922.58822791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13849649-DE5B-4B28-AAE5-D396435F1941</gtr:id><gtr:title>Macrophage-Microbe Interactions: Lessons from the Zebrafish Model.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6cddf6ba688576019b60385f37dd7b93"><gtr:id>6cddf6ba688576019b60385f37dd7b93</gtr:id><gtr:otherNames>Yoshida N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5aa656ab234800.65890015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6BABAA9-E875-4DF8-911F-1F2A99DA8271</gtr:id><gtr:title>Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.</gtr:title><gtr:parentPublicationTitle>mBio</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e535a360154e375aec24b4389d6fab43"><gtr:id>e535a360154e375aec24b4389d6fab43</gtr:id><gtr:otherNames>Jensen KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56dd66be123020.68008056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FA45780-0B17-4FCA-B1C3-52C06EA3474A</gtr:id><gtr:title>K63-Linked Ubiquitination Targets Toxoplasma gondii for Endo-lysosomal Destruction in IFN?-Stimulated Human Cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd444ef1fd890ab267251a70b0f22fca"><gtr:id>fd444ef1fd890ab267251a70b0f22fca</gtr:id><gtr:otherNames>Clough B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>58c96b434238d3.11250098</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8D5D4EA-304F-4249-A019-AF600AE9DF2A</gtr:id><gtr:title>Exposing Toxoplasma gondii hiding inside the vacuole: a role for GBPs, autophagy and host cell death.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9b91e8aeb584e7e6fa90f4a76d6594"><gtr:id>1e9b91e8aeb584e7e6fa90f4a76d6594</gtr:id><gtr:otherNames>Saeij JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>5aa656ab585b30.43780966</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9C27096-B81E-4620-AF87-9B0F6F449B37</gtr:id><gtr:title>Murine Gbp1 and Gbp2 are ubiquitinated independent of Toxoplasma gondii infection.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/335bcd929f925c27c5fd5615b6fd96ff"><gtr:id>335bcd929f925c27c5fd5615b6fd96ff</gtr:id><gtr:otherNames>Encheva V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>5aa656abdef877.94309499</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UP_1202/12</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>